Innate immune signaling drives late cardiac toxicity following DNA damaging cancer therapies
A. Shamseddine, S. Patel, V. Chavez…·A. M. Schmitt
This study identifies cGAS-STING signaling as a driver of late cardiac toxicity after DNA-damaging cancer therapies and shows that targeting this pathway can mitigate cardiotoxicity.